{"DataElement":{"publicId":"2182613","version":"1","preferredName":"Off Study Reason Text","preferredDefinition":"The text that describes the reason the participant went off study.","longName":"OFF_STUDY_RSN_TXT","context":"DCP","contextVersion":"1","DataElementConcept":{"publicId":"2012688","version":"3","preferredName":"Off Study Reason","preferredDefinition":"Reason that a patient/participant ends all activity associated with a clinical trial.","longName":"OFF_STUDY_RSN","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2660536","version":"1","preferredName":"Off Clinical Study","preferredDefinition":"No longer planned or scheduled (said of events).:Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, mechanism of human diseases, therapy, clinical trials, epidemiology, behavior and health services research. ","longName":"C40450:C15206","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Off","conceptCode":"C40450","definition":"No longer planned or scheduled (said of events).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Study","conceptCode":"C15206","definition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33E5C497-F2C5-4C81-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-27","modifiedBy":"ONEDATA","dateModified":"2007-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2390595","version":"1","preferredName":"Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE52ECB4-C378-617F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-08-16","modifiedBy":"ONEDATA","dateModified":"2005-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008554","version":"1","preferredName":"Treatment/Off-treatment Reasons","preferredDefinition":"justification for or explanation of the administration or cessation of therapy.","longName":"TX_OTX_RSNS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2C9BE32-8BDB-649C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A56E9E7B-DB46-1DF9-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2002-07-10","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2182614","version":"1","preferredName":"Off Study Reason Text","preferredDefinition":"an explanation of the cause of some phenomenon or action why the participant went off study._No longer participating in a study; not being followed and will not be retreated._An explanation of the cause of some phenomenon or action.","longName":"OFF_STUDY_REASON_TXT","context":"DCP","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008573","version":"1","preferredName":"Adverse Event Results","preferredDefinition":"the outcome or resolution of the patient's adverse events.","longName":"AE_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB869948-5E78-2537-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2979272","version":"1","preferredName":"Off Study Reason Text","preferredDefinition":"No longer participating in a study; not being followed and will not be retreated.:An explanation of the cause of some phenomenon or action.:Text; the words of something written.","longName":"C29851:C25638:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Off Study","conceptCode":"C29851","definition":"No longer participating in a study; not being followed and will not be retreated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C80BA7E-DE1B-D998-E040-BB89AD435B65","latestVersionIndicator":"Yes","beginDate":"2010-01-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2010-01-06","modifiedBy":"ONEDATA","dateModified":"2010-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D751C8E1-823C-1B6B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-05","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-04-05","modifiedBy":"MAESKEB","dateModified":"2010-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2179692","version":"1","longName":"TYPE OF CATEGORY","context":"DCP","ClassificationSchemeItems":[{"publicId":"2811734","version":"1","longName":"Case Report Forms","context":"DCP"},{"publicId":"2957372","version":"1","longName":"Case Report Forms Version 3","context":"DCP"}]},{"publicId":"2190530","version":"1","longName":"Demonstration Applications","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812349","version":"1","longName":"Rembrandt","context":"NCIP"}]},{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"2956215","version":"1","longName":"Off Study CRF","context":"NCIP"},{"publicId":"3943912","version":"1","longName":"All Mandatory CRF CDEs","context":"NCIP"}]},{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812377","version":"1","longName":"Bladder Cancer","context":"DCP"},{"publicId":"2812388","version":"1","longName":"Oral Leukoplakia","context":"DCP"},{"publicId":"2812415","version":"1","longName":"Sulindac for Breast Cancer","context":"DCP"},{"publicId":"2812399","version":"1","longName":"Polyphenon E for Cervical Ca","context":"DCP"},{"publicId":"2812364","version":"1","longName":"Barretts Esophagus","context":"DCP"},{"publicId":"2812516","version":"1","longName":"Subclinical Neoplastic Lesions","context":"DCP"},{"publicId":"2812502","version":"1","longName":"Unconjugated Isoflavones in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812194","version":"1","longName":"ALA PDT - Oral Leukoplakia","context":"DCP"},{"publicId":"2812157","version":"1","longName":"Melanoma Pathobiology - Lovastatin","context":"DCP"},{"publicId":"2812155","version":"1","longName":"Sporadic Colorectal Neoplasia - Atrovastatin","context":"DCP"},{"publicId":"2812189","version":"1","longName":"Polyphenon E - Pre-prostatectomy Prostate Cancer","context":"DCP"},{"publicId":"2812202","version":"1","longName":"DIM - Prostate Cancer","context":"DCP"},{"publicId":"2812188","version":"1","longName":"Se-Methyl-Seleno-L-Cystein (MSC) in Adult Men","context":"DCP"},{"publicId":"2812183","version":"1","longName":"Atrovastatin in Women at High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812177","version":"1","longName":"Safety Study of Resiquimod for Atyical Nevi","context":"DCP"},{"publicId":"2812184","version":"1","longName":"Spectral Markers in ASA","context":"DCP"},{"publicId":"2812190","version":"1","longName":"Acolbifene - High Risk for Breast Cancer","context":"DCP"},{"publicId":"2812154","version":"1","longName":"Bronchial Dysplasia - Sulindac","context":"DCP"},{"publicId":"2812182","version":"1","longName":"Tissue Effect of Finasteride - Prostate Cancer","context":"DCP"},{"publicId":"2812197","version":"1","longName":"Phase II Resiquimod - Atypical Nevi","context":"DCP"},{"publicId":"2812174","version":"1","longName":"Polyphenon E - Hormone Receptor-Negative Breast Cancer","context":"DCP"},{"publicId":"2812152","version":"1","longName":"Barretts Esophagus - ASA-Esomeprazole","context":"DCP"},{"publicId":"2812148","version":"1","longName":"SAMe - Hepatitis C cirrhosis","context":"DCP"},{"publicId":"2812102","version":"1","longName":"Budesonide Lung Nodules","context":"DCP"},{"publicId":"2812149","version":"1","longName":"Pancreatic Mucinous Neoplasms","context":"DCP"},{"publicId":"2812277","version":"1","longName":"Aminolevulinic Acid - Barrett's Esophagus","context":"DCP"},{"publicId":"2812258","version":"1","longName":"Drug and Carcinogen Enzymes - Resveratrol","context":"DCP"},{"publicId":"2812876","version":"1","longName":"Bronchial Dysplasia - Myo-Inositol","context":"DCP"},{"publicId":"2812151","version":"1","longName":"Prostate - Lycopene","context":"DCP"},{"publicId":"2812768","version":"1","longName":"PK and Safety - Novel Retinoid (9cUAB30)","context":"DCP"},{"publicId":"2812539","version":"1","longName":"Polyphenon E - Bladder Cancer","context":"DCP"},{"publicId":"2812553","version":"1","longName":"EGF Receptor Signaling in ACF","context":"DCP"},{"publicId":"2812551","version":"1","longName":"9cUAB30","context":"DCP"},{"publicId":"2812836","version":"1","longName":"Imiquimod for Atypical Nevi","context":"DCP"},{"publicId":"2812843","version":"1","longName":"Polyethylene Glycol - Colon Carcinogenesis","context":"DCP"},{"publicId":"2812949","version":"1","longName":"Exp. PK Formulations of SR13668","context":"DCP"},{"publicId":"2842768","version":"1","longName":"Letrozole - Breast Cancer","context":"DCP"},{"publicId":"2813002","version":"1","longName":"Sulindac - Increased Risk of Melanoma","context":"DCP"},{"publicId":"2812735","version":"1","longName":"3, 3-Diindolylmethane Cervical Intraepithelial","context":"DCP"},{"publicId":"2812736","version":"1","longName":"Transdermal 4-OHT vs oral TAM DCIS of the Breast","context":"DCP"},{"publicId":"2813043","version":"1","longName":"Ursodeoxycholic Acid - Barrett's Patients","context":"DCP"},{"publicId":"2812998","version":"1","longName":"Pioglitazone - Oral Leukoplakia","context":"DCP"},{"publicId":"2813064","version":"1","longName":"Erlotinib - Lesions of Lung","context":"DCP"},{"publicId":"2859628","version":"1","longName":"Breast Sulindac DFMO","context":"DCP"},{"publicId":"2979172","version":"1","longName":"MyoInositol Chemoprevention in Colitis-Assoc. Dysplasia","context":"DCP"},{"publicId":"2936518","version":"1","longName":"Polyphenon E in Women w/ Modulation of Arachidonic Acid","context":"DCP"},{"publicId":"3110219","version":"1","longName":"MSC and L SeMet in Adult Men","context":"DCP"},{"publicId":"3018781","version":"1","longName":"Metformin Colorectal Cancer","context":"DCP"},{"publicId":"3018782","version":"1","longName":"Resveratrol in Postmenopausal Women","context":"DCP"},{"publicId":"3114163","version":"1","longName":"Cholecalciferol and Genistein","context":"DCP"},{"publicId":"3152820","version":"1","longName":"Pioglitazone - Lung Pre-Surgical NSCLC","context":"DCP"},{"publicId":"3528035","version":"1","longName":"Docosahexaenoic Acid","context":"DCP"},{"publicId":"3182878","version":"1","longName":"Vitamin D - Bioactivity in the Skin","context":"DCP"},{"publicId":"3182879","version":"1","longName":"Metformin - Pre-Prostatectomy Prostate Cancer","context":"DCP"},{"publicId":"3293737","version":"1","longName":"UAB30 in NMSC","context":"DCP"},{"publicId":"3303133","version":"1","longName":"Pomegranate - Prostate Cancer","context":"DCP"},{"publicId":"3211792","version":"1","longName":"Barrett's Esophagus Chemoprevention Metformin","context":"DCP"}]},{"publicId":"2487057","version":"1","longName":"DCP Enterprise System Knowledgebase ","context":"DCP","ClassificationSchemeItems":[{"publicId":"2812178","version":"1","longName":"E-Progress Report","context":"DCP"}]},{"publicId":"3194026","version":"1","longName":"KAI Research","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812550","version":"1","longName":"General CDEs","context":"NCIP"},{"publicId":"3211761","version":"1","longName":"Study Completion","context":"NCIP"}]},{"publicId":"3335728","version":"1","longName":"Protocols","context":"ABTC","ClassificationSchemeItems":[{"publicId":"3335732","version":"1","longName":"ABTC 0904","context":"ABTC"}]},{"publicId":"3835419","version":"1","longName":"Pharmacovigilance-Gabapentin/Pregabalin","context":"DCI","ClassificationSchemeItems":[{"publicId":"3835424","version":"1","longName":"End of Study","context":"DCI"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"4111771","version":"1","longName":"UWI2013-00-01","context":"DCP"},{"publicId":"4915512","version":"1","longName":"UAZ2015-05-02","context":"DCP"},{"publicId":"3896537","version":"1","longName":"UWI2013-01-02","context":"DCP"},{"publicId":"3896538","version":"1","longName":"UAZ2013-01-01","context":"DCP"},{"publicId":"3694151","version":"1","longName":"MAY2012-00-01","context":"DCP"},{"publicId":"4261112","version":"1","longName":"UAZ2013-02-01","context":"DCP"},{"publicId":"4261412","version":"1","longName":"MDA2013-01-01","context":"DCP"},{"publicId":"4188651","version":"1","longName":"MDA2013-01-02","context":"DCP"},{"publicId":"4261411","version":"1","longName":"MAY2013-01-01","context":"DCP"},{"publicId":"4528052","version":"1","longName":"MAY2013-02-01","context":"DCP"},{"publicId":"4528055","version":"1","longName":"UAZ2014-03-01","context":"DCP"},{"publicId":"5889177","version":"1","longName":"MDA2016-08-02","context":"DCP"},{"publicId":"4528053","version":"1","longName":"NWU2014-03-01","context":"DCP"},{"publicId":"4528051","version":"1","longName":"MAY2013-02-02","context":"DCP"},{"publicId":"5612586","version":"1","longName":"MAY2016-07-01","context":"DCP"},{"publicId":"5441476","version":"1","longName":"MDA2014-04-02","context":"DCP"},{"publicId":"4915511","version":"1","longName":"UAZ2015-05-01","context":"DCP"},{"publicId":"4528054","version":"1","longName":"NWU2013-01-03","context":"DCP"},{"publicId":"5280818","version":"1","longName":"UWI2014-03-01","context":"DCP"},{"publicId":"5416571","version":"1","longName":"MDA2013-02-02","context":"DCP"},{"publicId":"5592146","version":"1","longName":"MAY2015-05-01","context":"DCP"},{"publicId":"5598962","version":"1","longName":"MDA2014-04-01","context":"DCP"},{"publicId":"5981652","version":"1","longName":"UAZ2017-09-02","context":"DCP"},{"publicId":"5280813","version":"1","longName":"NWU2015-06-02","context":"DCP"},{"publicId":"5889185","version":"1","longName":"UWI2016-08-01","context":"DCP"},{"publicId":"6005698","version":"1","longName":"MAY2017-09-01","context":"DCP"},{"publicId":"5889176","version":"1","longName":"MDA2016-07-02","context":"DCP"},{"publicId":"5889179","version":"1","longName":"NWU2016-08-02","context":"DCP"},{"publicId":"4528056","version":"1","longName":"NWU2013-02-01","context":"DCP"},{"publicId":"5889178","version":"1","longName":"MDA2017-09-03","context":"DCP"},{"publicId":"5889187","version":"1","longName":"UWI2017-09-01","context":"DCP"},{"publicId":"5280817","version":"1","longName":"UWI2016-07-01","context":"DCP"},{"publicId":"5280816","version":"1","longName":"UWI2015-05-01","context":"DCP"},{"publicId":"5889180","version":"1","longName":"NWU2017-09-01","context":"DCP"},{"publicId":"5280814","version":"1","longName":"NWU2015-06-03","context":"DCP"},{"publicId":"5280811","version":"1","longName":"NWU2014-04-01","context":"DCP"},{"publicId":"5280812","version":"1","longName":"NWU2015-06-01","context":"DCP"},{"publicId":"5280815","version":"1","longName":"NWU2015-06-04","context":"DCP"}]},{"publicId":"5635298","version":"1","longName":"All Mandatory CRF CDEs","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635299","version":"1","longName":"Mandatory CRF CDEs","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000503","version":"1","longName":"Off Treatment","context":"NCI Standards"},{"publicId":"10000423","version":"1","longName":"Off Study","context":"NCI Standards"}]},{"publicId":"6272292","version":"1","longName":"NINDS","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3151143","version":"1","longName":"Protocol Experience","context":"NCIP"},{"publicId":"3151278","version":"1","longName":"Off Treatment / Off Study","context":"NCIP"},{"publicId":"3151281","version":"1","longName":"Study Discontinuation / Completion","context":"NCIP"}]}],"AlternateNames":[{"name":"OFF_STUDY_RSN_TXT","type":"USED_BY","context":"NCIP"},{"name":"ENGLISH","type":"CONTEXT NAME","context":"DCP"},{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"DCI","type":"USED_BY","context":"DCI"},{"name":"ABTC","type":"USED_BY","context":"ABTC"},{"name":"OFF_STUDY_RSN_TXT","type":"USED_BY","context":"CITN"},{"name":"OFF_STUDY_RSN_TXT","type":"USED_BY","context":"OHSU Knight"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"NCIP","type":"USED_BY","context":"NCIP"},{"name":"Status at final study contact other specify","type":"NINDS Alt Name","context":"NCIP"},{"name":"NHLBI","type":"USED_BY","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Off Study Other, Specify","type":"Preferred Question Text","description":"Off Study Other, Specify","url":null,"context":"DCP"},{"name":"DESK Document Text","type":"Alternate Question Text","description":"Off Study Other Comments","url":null,"context":"DCP"},{"name":"Reason","type":"Alternate Question Text","description":"Reason","url":null,"context":"DCP"},{"name":"NINDS CDE Project","type":"REFERENCE","description":"NINDS CDE Project","url":"http://www.commondataelements.ninds.nih.gov/","context":"NCIP"},{"name":"DCRI Question","type":"Alternate Question Text","description":"Other  (please specify)","url":null,"context":"DCI"},{"name":"DCP Text 1","type":"Alternate Question Text","description":"Reason Explanation","url":null,"context":"DCP"},{"name":"DCP - Comments","type":"Alternate Question Text","description":"Comments","url":null,"context":"DCP"},{"name":"DCP Text 2","type":"Alternate Question Text","description":"Reason Off Study, Other Specify","url":null,"context":"DCP"},{"name":"Off TX Form","type":"Alternate Question Text","description":"Specify reason treatment ended","url":null,"context":"ECOG-ACRIN"},{"name":"Specify other:","type":"Alternate Question Text","description":"Specify other:","url":null,"context":"NHLBI"},{"name":"Specify other:","type":"Application Standard Question Text","description":"Specify other:","url":null,"context":"NHLBI"},{"name":"DCP-Text-3","type":"Alternate Question Text","description":"Reason off study other, specify","url":null,"context":"DCP"},{"name":"DCP-Text-4","type":"Alternate Question Text","description":"Reason off study , specify","url":null,"context":"DCP"},{"name":"DCP-Text-5","type":"Alternate Question Text","description":"Reason Off Study Other, specify","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"D751C8E1-8235-1B6B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-05","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-04-05","modifiedBy":"JKNABLE","dateModified":"2023-03-09","changeDescription":null,"administrativeNotes":"3/9/23 removed PCDC references/alts; they use an enumerated PV list. jk","unresolvedIssues":null,"deletedIndicator":"No"}}